TABLE 1.
Topical analgesia with opioid and opioid combinations
| Drug ED50, mM (95% conf limits) Ratio |
||||
|---|---|---|---|---|
| Lidocaine | Morphine | Meperidine | Methadone | |
| Alone | 2.3 (2, 3.4) | 6.3 (3.7, 8.3) | 1.8 (1.1, 2.4) | 5.0 (3.7, 6.8) |
| Combinations | ||||
| Lidocaine + | 0.8 (0.6, 1.1) | 0.7 (0.6, 0.9) | ||
| Meperidine | 3 | 2.5 | ||
| Lidocaine + | 0.6(0.4, 0.7) | 1.2 (0.9, 1.7) | ||
| Methadone | 4 | 4.2 | ||
| Morphine + | 2.2 (1.2, 2.6) | 0.72 (0.6, 0.8) | ||
| Meperidine | 2.7 | 2.4 | ||
| Morphine + | 0.8 (0.6, 1.1) | 1.6 (1.2, 2.1) | ||
| Methadone | 7.6 | 3.2 | ||
ED50 values were determined from dose-response curves and presented with 95% confidence limits. For lidocaine, the ED50 value was determined only from the initial portion of the curve. Combinations were also examined using increasing doses of a fixed ratio of the indicated drugs. ED50 values were determined and presented with the 95% confidence limits. The ratios of drug dose in combination to that of the drug alone are presented in bold. The relative potency of the various drugs in combination was compared with the same drug alone as a ratio. The fixed ratios were as follows: lidocaine/meperidine, 1; methadone/lidocaine, 2; morphine/meperidine, 3.5; methadone/morphine, 2